COMPAWANCT05560204
Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved 12 months later.
See at-risk trials from Prince of Wales Hospital, Shatin, Hong Kong
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Dec 31, 2026 to Dec 31, 2027 Show 5 more changesShow less
- Eligibility criteria revised
- Study completion pushed from Dec 31, 2027 to Apr 28, 2028
- Study sites: 1 to 3
- Secondary endpoints: details revised at 10 of 10 entries
- Study description expanded, about 3 words
Notable Eligibility criteria expanded, about 9 words Show 4 more changesShow less
- Primary endpoints: details revised at 1 of 1 entry
- Trial status changed: Enrolling by Invitation → Active, Not Recruiting
- Secondary endpoints: details revised at 1 of 10 entries
- Publications: details revised at 13 of 13 entries
Notable Phase: Not specified to Not applicablev3 Show 6 more changesShow less
- Primary completion date: Oct 31, 2026 to Dec 31, 2026
- Study completion date: Oct 30, 2027 to Dec 31, 2027
- Start date changed from estimate of Nov 1, 2022 to Jan 1, 2023
- Interventions: Combined Pulsed-field Ablation (PFA) (Procedure) to Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO) (Device)
- Secondary endpoints: details revised at 5 of 10 entries
- Study arms: 0 to 2
Notable Start date: Jun 1, 2022 to Nov 1, 2022v2 Show 10 more changesShow less
- Eligibility criteria expanded, about 14 words
- Primary endpoints: 3 to 1
- Enrollment target: 260 to 200
- Primary completion date: Dec 31, 2026 to Oct 31, 2026
- Study completion date: Jun 30, 2027 to Oct 30, 2027
- Interventions: Left Atrial Appendage Closure (Procedure) to Combined Pulsed-field Ablation (PFA) (Procedure)
- Secondary endpoints expanded, about 48 words
- Study description expanded, about 31 words
- Publications: 5 to 13
- Study title expanded, about 10 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Rate of >=moderate peri-device leak (i.e. >=3mm) on follow-up TEE
Timeframe: 45-90 days
Secondary (10)
LAAO technical success rate
Rate of procedural related complications
Total ablation time
LAAO procedural time
Need of additional transseptal puncture for LAAO
Show 5 moreShow less
Number of device recapture (full or partial)
Number of device used
PFA acute technical success
AF ablation procedural success
Number of Participants with 1-year clinical events
Arms and interventions
Watchman Flx ProActive comparator
Watchman Flx Pro device to be used for LAAO
AmuletActive comparator
Amulet device to be used for LAAO
Devices: Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO)
Sites
3 sites in 2 countries
Hong Kong 2, Macau 1